Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T18:32:37.565Z.
Consensus retrieved: 2026-10-06T15:19:19.118Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T18:32:37.565Z.
Quote observation: 2026-10-06T18:29:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b1195b951add05ab4c37664b10382d427b1d38f05de7a164f71fe4d518fffb76
FORWARD PE RATIO
N/A
ProMIS Neurosciences, Inc.
Market Cap
$82.14M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| ProMIS Neurosciences, Inc. (PMN) | $82.14M | N/A |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO)vs › | $81.84M | N/A |
| MediciNova, Inc. (MNOV)vs › | $82.45M | N/A |
| Humacyte, Inc. (HUMA)vs › | $82.49M | N/A |
| LENSAR Inc (LNSR)vs › | $82.78M | N/A |
| Cardiff Oncology, Inc. (CRDF)vs › | $82.85M | N/A |
| Nutriband Inc. (NTRB)vs › | $81.14M | 4.25 |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $80.90M | N/A |
| Citius Oncology, Inc. (CTOR)vs › | $80.88M | 8.70 |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $83.61M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
Consensus estimates for this stock are reported in USD, while the share price trades in USD — so per-fiscal-year implied multiples can't be computed honestly here. The analyst estimates table shows the consensus figures with their correct currency label.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
